[1] | Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365: 1415–28. |
[2] | Hoebel S, Malan L, De Ridder H. Differences in MetS marker prevalence between black African and Caucasian teachers from the North West Province: Sympathetic activity and ambulatory blood pressure in Africans (SABPA) Study. Journal of Endocrinology, Metabolism and diabetes South Africa. 2011; 16(1): 49-56. |
[3] | Rice BH, Cifelli CJ, Pikosky MA, Miller GD. Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research. Adv Nutr. 2011; 2(5): 396-407. |
[4] | Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome, definitions and controversies. BMC Med 2011; 2(4); 9-48. |
[5] | Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012; 59(7): 635-643. |
[6] | Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2009; 4(2): 113-119. |
[7] | World Health Organisation (WHO). Overweight and Obesity: Report of a WHO Consultation. WHO, 2006. |
[8] | Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metabolism.2008; 93 (11 Suppl1): S9-30. |
[9] | Gupta R, Gupta VP, Sarna M. Prevalence of coronary heart disease and risk factors in an urban Indian population Jaipur Heart Watch-2. Indian Heart J. 2002; 54(1): 59-66. |
[10] | Gupta R, Misra A. Type 2 diabetes in india: Regional Disparities. Br J Diabetes & Vascular Dis. 2007; 7:12-16. |
[11] | Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014; 943162. PMC 3966331. PMID 24711954. |
[12] | Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008; 216: 3-13. |
[13] | Bartness TJ, Song CK. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. J Lipid Res 2007; 48: 1655-72. |
[14] | Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-9. |
[15] | Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146- 54. |
[16] | Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-301. |
[17] | Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004; 314: 415-9. |
[18] | Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5. |
[19] | Kim JY, Ahn SV, Yoon JH, Koh SB, Yoon J, Yoo BS, et al. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care 2013; 36: 1547-53. |
[20] | Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70. |
[21] | Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 2008; 10: 131-7. |
[22] | Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-91. |
[23] | Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11: 11-8. |
[24] | Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14:741-51. |
[25] | Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14: 741-51. |
[26] | Alberti KG, Zimmet P, Shaw J. IDF epidemiology task force consensus group. Lancet. 2005; 66: 1059–62. |
[27] | Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: Continuing escalation and possible solutions. Indian J Med Res 2007; 125: 345-54. |
[28] | Chen G, Liu C, Yao J, Jiang Q, Chen N, Huang H, et al. Overweight, obesity, and their associations with insulin resistance and cell function among Chinese: A cross-sectional study in China. Metabolism 2010; 59: 1823-32. |
[29] | Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006; 26; 2200-7. |
[30] | Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian Subcontinent living in west London and their siblings in India. Lancet 1995; 345: 405-9. |
[31] | Scherer PE. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-45. |
[32] | Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian Subcontinent living in west London and their siblings in India. Lancet 1995; 345: 405-9. |
[33] | Mahadik SR, Deo SS, Mehtalia SD. Association of adiposity, inflammation and atherosclerosis: The role of adipocytokines and CRP in Asian Indian subjects. Metab Syndr Relat Disord 2008; 6: 121-8. |
[34] | Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome--The Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005; 54: 476-81. |
[35] | Banerji MA, Faridi N, Atluri R, Chaiken R, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 137-44. |
[36] | Tajtákova M, Petrásova D, Petrovicová J, Pytliak M, Semanová Z. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. Endocr Regul 2006; 40: 15-9. |
[37] | Santaniemi M, Kesäniemi YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006; 155: 745-50. |
[38] | Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 2007; 75: 235-40. |
[39] | Restituto P, Colina I, Varo JJ, Varo N. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 298: E1072-7. |
[40] | Bilgili S, Celebiler AC, Dogan A, Karaca B. Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr Regul 2008; 42: 63-8. |
[41] | You T, Nicklas BJ, Ding J, Penninx BW, Goodpaster BH, Bauer DC, et al. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci 2008; 63: 414-9. |
[42] | Sepulveda KK, Huffman FG, Mclean M, Zarini GG. Increased adiponectin among Cuban American type 2 diabetics with metabolic syndrome. FASEB J 2009; 23: 547-8. |
[43] | Mori Y, Hoshino K, Yokota K, Itoh Y, Tajima N. Role of hypoadiponectinemia in the metabolic syndrome and its association with post-glucose challenge hyper-free fatty acidemia: A study in prediabetic Japanese males. Endocrine 2006; 29: 357-61. |
[44] | Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: The Bogalusa Heart Study. Metabolism 2006; 55: 1551-7. |
[45] | Snehalatha C, Yamuna A, Ramachandran A.Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers. Diabetes Care 2008; 31: 2374-9. |
[46] | Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism 2004; 53: 1336-41. |
[47] | Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002; 10: 1104-10. |
[48] | Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulinresistance and metabolic syndrome in Japanese men. Metabolism 2007; 56: 1493-9. |
[49] | Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond) 2008; 32: 772-9. |
[50] | Tanianskiĭ DA, Firova EM, Shatilina LV, Denisenko AD. Adiponectin: Lowering in metabolic syndrome and independent relation to hypertriglyceridemia. Kardiologiia 2008; 48: 20-5. |
[51] | Ryu HK, Yu SY, Park JS, Choi YJ, Huh KB, Park JE, et al. Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients. J Am Coll Nutr 2010; 29: 171-8. |
[52] | Trayhurn P, Beattie JH 2001 Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329–339. |
[53] | McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S 2002 Resistin, central obesity, and type 2 diabetes. Lancet 359: 46–47. |
[54] | Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G 2001 Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745–E751. |
[55] | Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor _: a key component of the obesity-diabetes link. Diabetes 43:1271–1278. |
[56] | Matsuzawa Y, Funahashi T, Nakamura T 1999 Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann NY Acad Sci 892:146–154. |
[57] | Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79–83. |
[58] | Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595–1599. |
[59] | Kouidhi S, Jarboui S, Clerget Froidevaux MS, Abid H, Demeneix B, et al. (2010) Relationship between subcutaneous adipose tissue expression of leptin and obesity in Tunisian patients. Tunis Med 88: 569-572. |
[60] | Livshits G, Pantsulaia I, Gerber LM (2005) Association of leptin levels with obesity and blood pressure: possible common genetic variation. Int J Obes (Lond) 29: 85-92. |
[61] | Paz-Filho GJ, Volaco A, Suplicy HL, Radominski RB, Boguszewski CL (2009) Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome. Arg Bras Endocrinol Metabol 53: 1088-1095. |
[62] | Heptulla R, Smitten A, Teague B, Tamborlane WV, Ma YZ, et al. (2001) Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rythmicity. J Clin Endocrinol Metab 86: 90-96. |
[63] | Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002; 32 Suppl 3: 14-23. |